Join Hesperos at the 2026 MPS World Summit in Washington, DC If you are attending the MPS World Summit (Washington, DC, 26 – 29 May 2026), please stop by Booth 523 to learn more about how … Read More
Hesperos and UCF publish new study in Alzheimer’s and Dementia demonstrating peripheral neuromuscular pathology is NOT CNS dependent in Alzheimer’s Disease
A 4-organHuman-on-a-Chip® model was used to study the safety profile of tradipitant, the results supported its recent approval for motion sickness.
Featured on the cover of Advanced Science, our study presents a human-derived Malaria-on-a-Chip system that captures the biology of infection and delivers actionable insights for real-world therapeutic translation.
Hesperos and AsedaSciences announce a strategic channel sales partnership combining Human-on-a-Chip® and AI-driven 3RnD® to advance safer, more efficient drug and chemical development.
Hesperos’ Human-on-a-Chip® technology earns recognition in a Nature Lab Animal article highlighting advancements in human-relevant, new alternative methods (NAMs) models and publishes new research advancing its sarcopenia-on-a-chip system.
Hesperos and Oriental Yeast Co. form a strategic partnership to expand access to Human-on-a-Chip® services across Asia, accelerating safer, more effective preclinical drug development.